UTHSC professor’s startup receives federal grants, LaunchTN funds for leukemia therapy

//UTHSC professor’s startup receives federal grants, LaunchTN funds for leukemia therapy

UTHSC professor’s startup receives federal grants, LaunchTN funds for leukemia therapy

There is a protein called MDM2, which helps cancer cells survive, allowing them to quickly grow large. But by degrading the MDM2 protein, cancer cells will die, stopping tumor growth — and this is what University of Tennessee Health Science Center (UTHSC) faculty member Wei Li, Ph.D., hopes to do. Li is the founder of SEAK Therapeutics, a UTHSC-connected startup that’s in the early stages of developing a compound called SEAK-114, which is expected to act as a targeted leukemia therapy. Li…

Article by [author-name] (c) Technology News - Technology News Headlines | Bizjournals.com - Read full story here.

By | 2021-12-08T04:03:03+00:00 December 8th, 2021|Technology|

About the Author: